3rd Quarter - Report
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmaceutical Supply Chain. H.R.2213: Medical Supply Chain Resiliency Act. Issues related to the 340(b) program. H.R.1492/S.832: EPIC Act of 2025.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SOPHIE KHANAHMADI | Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions |
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter |
Trade (domestic/foreign) TRD
Issues related to USTR/trade.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SOPHIE KHANAHMADI | — |
| ALANNA TEMME | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.